secwatch.observer — SEC 8-K summary
======================================

Issuer:     NIKA PHARMACEUTICALS, INC (NIKA)
CIK:        0001145604
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001826466-24-000096
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.01, 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nika cancels May 2024 acquisition of Nika Pharmaceuticals Ltd; auditor resigns
------------------------------------------------------------------------------

- On Aug 18, 2024, board cancelled the acquisition of Nika Pharmaceuticals, Ltd. effective May 9, 2024; subsidiary returned to Savov on Aug 23.
- Nika no longer owns Nika Europe, Ltd. nor the factory/land assets acquired in May 2024.
- Independent auditor Fruci & Associates II, PLLC resigned on Aug 21, 2024; company seeking new auditor.
- Company states it will try to publish its 10-Q as early as possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145604/000182646624000096/0001826466-24-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145604/000182646624000096/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001826466-24-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer